Doberstein et al. found that PAX2 binds to the A Disintegrin and metalloproteinase domain-containing protein 10 (ADAM10) promoter and that inhibiting PAX2 expression significantly reduces the expression levels of ADAM10 protein in RCC cells [14]. This evidence concerns the gene ADAM10 and renal cell carcinoma.